PetCaseFinder

Peer-reviewed veterinary case report

Brain region-specific and systemic transcriptomic alterations in a human alpha-synuclein overexpressing rat model.

Journal:
Aging
Year:
2025
Authors:
Hoof, Vivien et al.
Affiliation:
Department of Genetics/Epigenetics · Germany
Species:
rodent

Abstract

Synucleinopathies are age-dependent neurodegenerative diseases characterized by alpha-synuclein accumulation with distinct vulnerabilities across brain regions. Understanding early disease stages is essential to uncover initial molecular changes that might enable earlier diagnosis and causal therapy. In this study, we profiled longitudinal and brain region-resolved gene expression changes in a rat model of synucleinopathies overexpressing human. Transcriptomic analyses were performed on gene and transcript level of striatal, frontocortical, and cerebellar tissue in 5- and 12-month-old transgenic (BAC SNCA) and wild type rats revealing thatoverexpression leads to age-dependent transcriptomic changes that largely occur region-specific. In frontal cortex, dysregulation of myelination-associated genes agreed with Parkinson patient data as shown before. In addition, BAC SNCA rats displayed more gene expression changes at younger age, with a common and characteristic alteration pattern across all three examined brain regions. We also identified a cross-regional set of differential genes that were affected byoverload. This set was also partially reflected in the gut transcriptome of the same rat model, suggesting a systemic impact ofoverload. Taken together, our findings highlight both brain region-specific vulnerabilities and global molecular perturbations associated with alpha-synuclein biology and provide insights into early transcriptomic changes in synucleinopathies.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/41117843/